Editorial: Engineered Adjuvants and Carriers for an Animal Infectious Disease Vaccine

Editorial: Engineered Adjuvants and Carriers for an Animal Infectious Disease Vaccine

Bibliographic Details
Main Authors:	Sankar Renu, Heather L. Wilson, Kaissar Tabynov, Jagadish Hiremath
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Bioengineering and Biotechnology
Subjects:	nanoparticles vaccines adjuvants Hsp90 polyphosphazenes immunity
Online Access:	https://www.frontiersin.org/articles/10.3389/fbioe.2021.692634/full

Similar Items

Polyphosphazenes as Adjuvants for Animal Vaccines and Other Medical Applications
by: Dylan J. Chand, et al.
Published: (2021-03-01)

Experimental PCEP-Adjuvanted Swine Influenza H1N1 Vaccine Induced Strong Immune Responses but Did Not Protect Piglets against Heterologous H3N2 Virus Challenge
by: Royford Bundi Magiri, et al.
Published: (2020-05-01)

Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide
by: Edwin F. Sánchez-López, et al.
Published: (2019-03-01)

Caspase-1 Dependent IL-1β Secretion and Antigen-Specific T-Cell Activation by the Novel Adjuvant, PCEP
by: Sunita Awate, et al.
Published: (2014-06-01)

Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP
by: Sarah M. Valencia, et al.
Published: (2021-08-01)

A recombinant Artemisia vulgaris pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice
by: Meruert Babayeva, et al.
Published: (2022-11-01)

Chemistry and applications of polyphosphazenes /
by: 265348 Allcock, Harry R.
Published: (2003)

Applicative aspects of poly(organophosphazenes) /
by: Gleria, Mario, et al.
Published: (c200)

Phosphazenes : a worldwide insight /
by: Gleria, Mario, et al.
Published: (c200)

Promising Adjuvants and Platforms for Influenza Vaccine Development
by: Wandi Zhu, et al.
Published: (2021-01-01)

Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines
by: Xiaochen Gong, et al.
Published: (2022-11-01)

An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators
by: Nidhi Chauhan, et al.
Published: (2017-05-01)

Evaluation of a SARS-CoV-2 spike protein ectodomain subunit vaccine with a squalene emulsion adjuvant in rodents and rhesus macaques
by: Maxim Solomadin, et al.
Published: (2023-08-01)

In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives
by: Yarong Zeng, et al.
Published: (2023-12-01)

Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases
by: Giuseppe Stefanetti, et al.
Published: (2022-01-01)

Heat Shock Proteins 90 kDa: Immunomodulators and Adjuvants in Vaccine Design Against Infectious Diseases
by: Mariana G. Corigliano, et al.
Published: (2021-01-01)

A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats
by: Kairat Tabynov, et al.
Published: (2022-03-01)

Kajian Heat Shock Protein 90 (HSP90) dalam Pencarian Kandidat Penghambatnya melalui Ekplorasi Bahan Alam Indonesia
by: Rehmadanta Sitepu
Published: (2019-03-01)

Cytosolic Hsp90 Isoform-Specific Functions and Clinical Significance
by: Samarpan Maiti, et al.
Published: (2022-08-01)

The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep
by: Cheng Chang, et al.
Published: (2023-01-01)

Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
by: Jing-Xing Yang, et al.
Published: (2022-02-01)

Gold nanoparticles as an antigen carrier & an adjuvant /
by: Dykman, L. A. (Lev Abramovich)
Published: (2010)

Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants
by: Abdellatif Bouazzaoui, et al.
Published: (2021-01-01)

Overview of vaccine adjuvants
by: Zhenchuan Wu, et al.
Published: (2021-09-01)

Particulate and non-particle adjuvants in Leishmaniasis vaccine designs: A review
by: Kübra Kelleci, et al.
Published: (2023-01-01)

Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases
by: Seyed Davoud Jazayeri, et al.
Published: (2021-06-01)

Licensed liposomal vaccines and adjuvants in the antigen delivery system
by: Yuriy Krasnopolsky, et al.
Published: (2022-12-01)

Discovery and development of natural heat shock protein 90 inhibitors in cancer treatment
by: Yong Li, et al.
Published: (2012-06-01)

Vaccine adjuvants and delivery systems /
by: Manmohan Singh, 1964 Nov. 8-
Published: (2007)

Biodistribution and Adjuvant Effect of an Intranasal Vaccine Based on Chitosan Nanoparticles against Paracoccidioidomycosis
by: Samuel Rodrigues Dos Santos Júnior, et al.
Published: (2023-02-01)

ENHANCEMENT OF THE IMMUNE RESPONSE OF CHICKENS VACCINATED WITH ADJUVANTED LIVE NEWCASTLE DISEASE VIRUS VACCINE
by: Yasmin Shawky, et al.
Published: (2023-01-01)

17-AAG-Induced Activation of the Autophagic Pathway in <i>Leishmania</i> Is Associated with Parasite Death
by: Antonio Luis de O. A. Petersen, et al.
Published: (2021-05-01)

Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy
by: Ángela Marrugal, et al.
Published: (2023-09-01)

Inhibition of Embryonic HSP 90 Function Promotes Variation of Cold Tolerance in Zebrafish
by: Bingshe Han, et al.
Published: (2020-12-01)

Application of built-in adjuvants for epitope-based vaccines
by: Yao Lei, et al.
Published: (2019-01-01)

Adjuvants in vaccines registered for human use
by: Filipić Brankica, et al.
Published: (2019-01-01)

Immunogenicity of Different Types of Adjuvants and Nano-Adjuvants in Veterinary Vaccines: A Comprehensive Review
by: Soren Nooraei, et al.
Published: (2023-02-01)

Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting
by: Alice Gutjahr, et al.
Published: (2016-10-01)

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
by: Marina Luchner, et al.
Published: (2021-01-01)

Role of Heat Shock Proteins (HSP70 and HSP90) in Viral Infection
by: Anna Lubkowska, et al.
Published: (2021-08-01)